Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > When are any warrants expiring-----
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12061)
•••
Comment by ScienceFirston Apr 18, 2022 3:20pm
107 Views
Post# 34610971

RE:RE:RE:RE:RE:RE:RE:RE:RE:When are any warrants expiring-----

RE:RE:RE:RE:RE:RE:RE:RE:RE:When are any warrants expiring-----The molecule of Prof. McFarland alone couldn't do the job.   It took her less than 1y to create the molecule.  That was step 1 of many.  The rest is all the work that had to be done around it so the molecule could retain its full potential.  IBM, Intel, Dr. Rueck, dosimetry planning, all these complex formulas, choosing the right dosage, protecting the bladder wall, Rutherrin (TLD-1433 + transferrin to give Rutherrin), all the animal testings, manufacturing good practices, etc ...  The difference between Photofrin and what we have now (a FastTrack and hopefully a FDA Breakthrough designation). Not bad when comparing to big pharmas that are still relying on immunotherapies and combos.  Your post lacks perspectives and sounds like one that has been sued by TLT.

_________________________

FGPstock - (4/18/2022 2:52:15 PM)
RE:RE:RE:RE:RE:RE:RE:RE:When are any warrants expiring-----

bEEN here too long... big fan of sherri and a viable cure for cancer, not a big fan of management and imo, they are self-serving and not the best at running a trial...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities